Perrigo and Dr. Reddy’s are asking a federal court in Texas to approve a settlement of a patent infringement lawsuit over the psoriasis drug Sernivo.
The parties said in a Nov. 27 joint motion that they have reached a settlement agreement. They did not disclose the terms of the deal.
Sernivo spray’s annual sales are around $13.9 million, according to the research firm Iqvia. The drug treats mild-to-moderate plaque psoriasis in adults. The potential market for the drug is huge: Nearly 7.5 million people in the U.S. are affected by the condition.
Dr. Reddy’s is still suing